JESSICA SCHRECK: Open Payments
NPI 1013254226 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 67 payments from 35 companies in 2025. Trend: 2023 $1,008 · 2024 $3,618 · 2025 $1,492
Food & beverage: $1,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $126 |
| Merck Sharp & Dohme LLC | 5 | $123 |
| PFIZER INC. | 5 | $121 |
| GlaxoSmithKline, LLC. | 5 | $107 |
| Daiichi Sankyo Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| Kite Pharma, Inc. | 2 | $49 |
| Alexion Pharmaceuticals, Inc. | 2 | $49 |
Products named: KEYTRUDA, JEMPERLI, ICLUSIG, Enhertu, EPKINLY, IBRANCE, VENCLEXTA, Yescarta.
Industry payments across AZ — which companies pay providers there.
